^○Makoto Nishio¹, Takashi Seto², Martin Reck³, Edward B. Garon⁴, Kazuto Nishio⁵, Kazuo Kasahara⁶, Kazumi Nishino⁷, Miyako Satouchi⁸, Kiyotaka Yoh⁹, Hidetoshi Hayashi¹⁰, Kazuko Sakai⁵, Sotaro Enatsu¹¹, Tomoko Matsui¹¹, Sunoj Chacko Varughese¹², Michelle Carlsen¹³, Carla M. Visseren-Grul¹⁴, Kazuhiko Nakagawa¹ (1.Department of Thoracic Medical Oncology, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan, 2.Department of Thoracic Oncology, NHO Kyushu Cancer Center, Fukuoka, Japan, 3.Department of Thoracic Oncology, Airway Research Center North, German Center for Lung Research, LungClinic, Grosshansdorf, Germany, 4.David Geffen School of Medicine at UCLA/TRIO-US Network, Los Angeles, USA, 5.Department of Genome Biology, Kindai University Faculty of Medicine, Osaka, Japan, 6.Department of Pulmonary Medicine and Oncology, Nippon Medical School Hospital, Tokyo, Japan, 7.Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan, 8.Department of Thoracic Oncology, Hyogo Cancer Center, Hyogo, Japan, 9.Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan, 10.Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka, Japan, 11.Eli Lilly Japan K.K., Kobe, Japan, 12.Statistics, Eli Lilly Services India Pvt. Ltd., Bengaluru, India, 13.Eli Lilly and Company, Indianapolis, USA, 14.Eli Lilly Netherlands, Utrecht, The Netherlands)

^○Hidehito Horinouchi¹, D. Ross Camidge², Shun Lu³, Pascale Tomasini⁴, Penelope Bradbury⁵, Michael Oh⁶, Jenny G. Parvani⁷, P. K. Epling-Burnette⁷, Izhar Batth⁷, Ronald Pandoy⁷, Weihua Shi⁷, Summer Xia⁷, Christine K. Ratajczak⁷, Vincent Blot⁷, Jonathan Goldman⁶ (1.National Cancer Center Hospital, Tokyo, Japan, 2.University of Colorado Cancer Center, Aurora, CO, USA, 3.Shanghai Chest Hospital, School of Medicine, Shanghai, China, 4.Hôpitaux Universitaires de Marseille Timone, Marseille, France, 5.Princess Margaret Cancer Centre, Toronto, ON, Canada, 6.David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA, USA, 7.AbbVie Inc, North Chicago, IL, USA)

^○Hiroaki Akamatsu¹, Natasha B Leighl², Sun Min Lim³, Ying Cheng⁴, Anna R Minchom⁵, Melina E Marmarelis⁶, Rachel E Sanborn⁷, James Chih-Hsin Yang⁸, Baogang Liu⁹, Thomas John¹⁰, Bartomeu Massuti¹¹, Alexander I. Spira¹², John Xie¹³, Debopriya Ghosh¹⁴, Ali Alhadab¹⁵, Remy B Verheijen¹⁶, Mohamed Gamil¹⁷, Joshua M Bauml¹⁸, Mahadi Baig¹⁹, Antonio Passaro²⁰ (1.Wakayama Medical University, 2.Princess Margaret Cancer Centre, Toronto, ON, Canada, 3.Yonsei University College of Medicine, Seoul, South Korea, 4.Jilin Cancer Hospital, Changchun, China, 5.The Royal Marsden Hospital and The Institute of Cancer Research, Sutton, UK, 6.Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA, 7.Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR, USA, 8.National Taiwan University Cancer Center, Taipei, Taiwan, 9.Harbin Medical University Cancer Hospital, Harbin, China, 10.Peter MacCallum Cancer Centre, The University of Melbourne, Melbourne, Australia, 11.Alicante University Dr. Balmis Hospital, ISABIAL, Alicante, Spain, 12.Virginia Cancer Specialists, Fairfax, VA, USA, 13.Janssen Research ＆ Development, Raritan, NJ, USA, 14.Janssen Research ＆ Development, Raritan, NJ, USA, 15.Janssen Research ＆ Development, San Diego, CA, USA, 16.Janssen Research ＆ Development, Leiden, The Netherlands, 17.Janssen Research ＆ Development, Spring House, PA, USA, 18.Janssen Research ＆ Development, Spring House, PA, USA, 19.Janssen Research ＆ Development, Raritan, NJ, USA, 20.European Institute of Oncology IRCCS, Milano, Italy)

^○森川 慶¹, 田中 寿志², 高田 佐織³, 渡部 聡⁴, 岸 一馬⁵, 副島 研造⁶, 解良 恭一⁷, 各務 博⁷, 吉村 健一⁸, 松谷 哲行⁹, 関 順彦¹⁰ (1.聖マリアンナ医科大学 呼吸器内科, 2.弘前大学医学部付属病院, 3.杏林大学医学部附属病院, 4.新潟大学医歯学総合病院, 5.東邦大学医療センター大森病院, 6.山梨大学病院, 7.埼玉医科大学国際医療センター, 8.広島大学病院, 9.帝京大学溝口病院, 10.帝京大学病院)

^○時任 高章^1,3, 三浦 理^2,3, 三角 俊裕³, 吉岡 弘鎮³, 福原 達朗³, 佐藤 悠城³, 白石 祥理³, 楠原 政一郎³, 赤松 弘朗³, 倉田 宝保³, 加藤 晃史³, 堀之内 秀仁³, 滝口 裕一³, 後藤 康洋³, 田中 謙太郎³, 森 雅秀³, 池田 慧³, 市原 英基³, 田中 洋史^2,3, 岡本 浩明³ (1.久留米大学病院, 2.新潟県立がんセンター新潟病院, 3.胸部腫瘍臨床研究機構（TORG）)

^○Toshihide Yokoyama¹, Hiroshige Yoshioka², Atsushi Nakamura³, Toshihiro Misumi⁴, Hidetoshi Itani⁵, Motoko Tachihara⁶, Kaoru Tanaka⁷, Hiroaki Akamatsu⁸, Akira Ono⁹, Toshiyuki Harada¹⁰, Ken Masubuchi¹¹, Yuki Misumi¹², Satoru Miura¹³, Junko Tanizaki^7,14, Shuji Murakami¹⁵, Takehito Shukuya¹⁶, Hideki Ishikawa¹⁷, Nobuyuki Yamamoto⁸, Hiroaki Okamoto¹², Takayasu Kurata² (1.Department of Respiratory Medicine, Kurashiki Central Hospital, Kurashiki, Japan, 2.Department of Thoracic Oncology, Kansai Medical University Hospital, Osaka-Hirakata, Japan, 3.Department of Pulmonary Medicine, Sendai Kousei Hospital, Sendai, Japan, 4.Department of Data Science, National Cancer Center Hospital East, Tokyo, Japan, 5.Department of Respiratory Medicine, Japanese Red Cross Ise Hospital, Ise, Japan, 6.Division of Respiratory Medicine, Kobe University Hospital, Kobe, Japan, 7.Department of Medical Oncology, Kindai University Hospital, Osaka-Sayama, Japan, 8.Internal Medicine III, Wakayama Medical University, Wakayama, Japan, 9.Division of Thoracic Oncology, Shizuoka Cancer Center, Shizuoka, Japan, 10.Respiratory Disease Center, Independent Administrative Institution, Organization for Promotion of Regional Medical Functions Hokkaido Hospital, Hokkaido, Japan, 11.Department of Respiratory Medicine, Gunma Prefectural Cancer Center, Gunma, Japan, 12.Department of Respiratory Medicine, Yokohama Municipal Citizen's Hospital, Yokohama, Japan, 13.Department of Internal Medicine, Niigata Cancer Center Hospital, Niigata, Japan, 14.Department of Medical Oncology, Kishiwada City Hospital, Osaka-Kishiwada, Japan, 15.Department of Thoracic Oncology, Kanagawa Cancer Center, Kanagawa, Japan, 16.Department of Respiratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan, 17.Department of Molecular-Targeting Cancer Prevention, Kyoto Prefectural University of Medicine, Kyoto, Japan)